Velpatasvir

Chemical formula: C₄₉H₅₄N₈O₈  Molecular mass: 883.019 g/mol  PubChem compound: 67683363

Active ingredient description

Velpatasvir is a HCV inhibitor targeting the HCV NS5A protein, which is essential for both RNA replication and the assembly of HCV virions. In vitro resistance selection and cross-resistance studies indicate velpatasvir targets NS5A as its mode of action.

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 1377049-84-7
DrugBank Drug: DB11613
KEGG Drug: D10806
PubChem Compound: 67683363
RxNorm Ingredient: 1799206
SNOMED-CT Concept: 719641001
Velpatasvir (substance)
UNII Identifier: KCU0C7RS7Z
VELPATASVIR

Medicines

Velpatasvir is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.